These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 5019448

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A, Damato VD, Germinario L, Campanella G, Boccuni N.
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].
    Charlebois G, Cadotte M, Barbeau A.
    Union Med Can; 1972 May; 101(5):893-5. PubMed ID: 4666894
    [No Abstract] [Full Text] [Related]

  • 6. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L, Campanella G, D'Addabbo A.
    Acta Neurol (Napoli); 1971 May; 26(4):423-35. PubMed ID: 5132824
    [No Abstract] [Full Text] [Related]

  • 7. [Penicillamine treatment of Wilson's disease].
    Falkmer S, Samuelson G, Sjölin S.
    Lakartidningen; 1969 May 14; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract] [Full Text] [Related]

  • 8. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V, Di Leo V, Lamboglia F, Bowlus CL, Tseng SC, D'Incà R, Irato P, Burra P, Martines D, Sturniolo GC.
    Scand J Gastroenterol; 2007 Dec 14; 42(12):1495-500. PubMed ID: 17994470
    [Abstract] [Full Text] [Related]

  • 9. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S, Samuelson G, Sjölin S.
    Pediatrics; 1970 Feb 14; 45(2):260-8. PubMed ID: 5413388
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP, Tauxe WN, McCall JT, Gross JB, Randall RV.
    Trans Am Neurol Assoc; 1969 Feb 14; 94():34-7. PubMed ID: 5374484
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I, Broussolle E, Neuschwander P, Confavreux C, Fontanges T, Accominotti M, Chazot G.
    Rev Neurol (Paris); 1993 Feb 14; 149(6-7):393-7. PubMed ID: 8303158
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F, Cardin R, D'inca R, Naccarato R, Sturniolo GC.
    J Lab Clin Med; 2003 Jun 14; 141(6):372-7. PubMed ID: 12819634
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.